08:09 AM EDT, 03/18/2025 (MT Newswires) -- Crescita Therapeutics ( CRRTF ) , a dermatology company, on Tuesday said its fourth-quarter net loss widened as revenue rose.

The net loss increased to $162,000 from $150,000 in the prior year period.

Revenue advanced to $7 million from $4.7 million in the previous corresponding quarter. The reimbursement of US$1.2 million received from a manufacturing client and higher skincare revenue drove the revenue increase.